Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 10/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.31 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.31 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.31 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.31 |
| ▸ | PRKAG3 | Q9UGI9 | 1/20 | 0.31 |
| ▸ | PRKAG2 | Q9UGJ0 | 1/20 | 0.31 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20230940 | 0.86 | HRH3 (0.34) | HRH3NPC1PRKAB2PRKAG1PRKAA2 | |
| SCHEMBL21898973 | 0.86 | HRH3 (0.33) | HRH3 | |
| SCHEMBL20325081 | 0.81 | HRH3 (0.35) | HRH3NPC1PRKAB2PRKAG1PRKAA2 | |
| SCHEMBL24856336 | 0.76 | HRH3 (0.32) | HRH3 | |
| SCHEMBL24475383 | 0.75 | NPC1 (0.44) | HRH3NPC1SLC6A4 | |
| SCHEMBL19606310 | 0.75 | KCNQ3 (0.34) | HRH3NPC1 | |
| SCHEMBL23868233 | 0.73 | NPC1 (0.38) | HRH3NPC1PRKAB2PRKAG1PRKAA2 | |
| SCHEMBL20805548 | 0.73 | SPHK2 (0.33) | — | |
| SCHEMBL20232140 | 0.73 | NPC1 (0.31) | HRH3NPC1SLC6A4 | |
| SCHEMBL29343513 | 0.73 | BCHE (0.39) | HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024150815-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | 田辺三菱製薬株式会社 | 2024-07-18 | — | — | WO | disclosed |